$CVKD insider trading
Over the last 12 months, Cadrenal Therapeutics insiders reported no purchases and 19 sales totaling $694K across SEC Form 4 filings. 100% of those filings were made under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $694K 19 events
- Events · 12m
- 19 Form 4 filings, grouped
- Insiders · 12m
- 2 distinct reporters
- 10b5-1 share
- 100% of events, not dollars
All insider trades
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jun 29, 2026 | Pham Quang XChairman and CEO · O·D·10% | ▼ Sale | 7,400 | $3.03 | $22K | -7% | plan |
| Jun 26, 2026 | Pham Quang XChairman, CEO and Interim CFO · O·D·10% | ▼ Sale | 11,156 | $3.04 | $34K | -9.5% | plan · 2 tranches |
| Jun 23, 2026 | Pham Quang XChairman, CEO and Interim CFO · O·D·10% | ▼ Sale | 11,444 | $3.48 | $40K | -8.9% | plan · 2 tranches |
| Jun 17, 2026 | Pham Quang XChairman, CEO and Interim CFO · O·D·10% | ▼ Sale | 4,126 | $3.18 | $13K | -3.1% | plan · 2 tranches |
| Jun 15, 2026 | Pham Quang XChairman, CEO and Interim CFO · O·D·10% | ▼ Sale | 18,124 | $3.88 | $70K | -12% | plan · 3 tranches |
| Jun 10, 2026 | Pham Quang XChairman, CEO and Interim CFO · O·D·10% | ▼ Sale | 22,385 | $4.17 | $93K | -12.9% | plan · 3 tranches |
| Jun 5, 2026 | Pham Quang XCEO and Chairman · O·D·10% | ▼ Sale | 8,285 | $4.37 | $36K | -4.6% | plan · 3 tranches |
| Jun 2, 2026 | Pham Quang XCEO and Chairman · O·D·10% | ▼ Sale | 652 | $4.72 | $3K | -0.4% | plan · 2 tranches |
| May 28, 2026 | Pham Quang XCEO and Chairman · O·D·10% | ▼ Sale | 12,763 | $5.44 | $69K | -6.5% | plan · 3 tranches |
| May 22, 2026 | Pham Quang XCEO and Chairman · O·D·10% | ▼ Sale | 1,165 | $5.69 | $7K | -0.6% | plan |
| Dec 29, 2025 | Szot Matthew KChief Financial Officer · O | ▼ Sale | 9,933 | $6.97 | $69K | -100% | plan |
| Oct 27, 2025 | Szot Matthew KChief Financial Officer · O | ▼ Sale | 3,600 | $13.99 | $50K | -26.6% | plan · 2 tranches |
| Oct 27, 2025 | Pham Quang XCEO and Chairman · O·D·10% | ▼ Sale | 2,444 | $14.01 | $34K | -1.2% | plan · 2 tranches |
| Oct 13, 2025 | Pham Quang XCEO and Chairman · O·D·10% | ▼ Sale | 3,600 | $14.08 | $51K | -1.8% | plan · 2 tranches |
| Oct 13, 2025 | Szot Matthew KChief Financial Officer · O | ▼ Sale | 3,493 | $14.03 | $49K | -20.5% | plan · 2 tranches |
| Oct 6, 2025 | Szot Matthew KChief Financial Officer · O | ▼ Sale | 107 | $13.99 | $1K | -0.6% | plan |
| Oct 2, 2025 | Pham Quang XCEO and Chairman · O·D·10% | ▼ Sale | 500 | $14.13 | $7K | -0.2% | plan |
| Oct 1, 2025 | Szot Matthew KChief Financial Officer · O | ▼ Sale | 1,800 | $13.99 | $25K | -9.5% | plan · 2 tranches |
| Oct 1, 2025 | Pham Quang XCEO and Chairman · O·D·10% | ▼ Sale | 1,300 | $14.01 | $18K | -0.6% | plan · 2 tranches |
| Sep 25, 2025 | Szot Matthew KChief Financial Officer · O | ▼ Sale | 12,400 | $14.05 | $174K | -39.6% | plan · 2 tranches |
| Sep 25, 2025 | Pham Quang XCEO and Chairman · O·D·10% | ▼ Sale | 9,371 | $14.06 | $132K | -4.4% | plan · 2 tranches |
| Aug 28, 2025 | Szot Matthew KChief Financial Officer · O | ▼ Sale | 2,000 | $14 | $28K | -6% | plan · 2 tranches |
| Aug 28, 2025 | Pham Quang XCEO and Chairman · O·D·10% | ▼ Sale | 5,029 | $13.99 | $70K | -2.3% | plan · 2 tranches |
Every $CVKD filing on this page is one API call away
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Cadrenal Therapeutics filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $CVKD feed.